End Stage Renal DiseaseNCT04789122
Assessment of Poles' Attitudes Towards Living Kidney Donation
An observational study of End Stage Renal Disease, run by Andrzej Frycz Modrzewski Krakow University at 1 site in Poland.
Trial summary
The main goal of the project is to examine the public opinion on living kidney donation and to assess the knowledge of Poles in this field. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- End Stage Renal Disease
- What is being tested?
- Attitude assessment
- How many people
- 1,000 participants
- Where
- 1 sitePoland
- Study dates
- 10 Dec 2020to 20 Feb 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Poles randomly chosen from all voivodships,
Who may be able to join
- 18 years or older
- Polish citizenship
Who cannot join
- below 18 yers of age
- not Polish citizen
Trial locations and contacts
1 site in 1 country.
Poland1 site
Andrzej Frycz Modrzewski Krakow University
Krakow, Małopolska, 30-705
About this study
The main goal of the project is to examine the public opinion on living kidney donation and to assess the knowledge of Poles in this field.
Read the detailed description
Researchers also want to estimate how large percentage of the respondents will declare their willingness to donate a kidney to a stranger and what percentage of respondents would support a possible extension of the existing law on the collection, storage and transplantation of cells, tissues and organs of July 1, 2005 to include donation to a stranger.
- Conditions
- End Stage Renal Disease
- Being tested
- Attitude assessment
- Medical subject headings
- Kidney Failure, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Attitude assessmentOther
The study covered a representative group of 1000 people. Own questionnaire and standardized tools sent online via the Statistical Research and Analysis Office, in compliance with the privacy policy and personal data protection of the General Data Protection Regulation.
What is being measured
The primary outcome is the main question the study is designed to answer.
Questionnaire answers under statistical processing
Measured: 15.03.2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Mar 2021
- Study start10 Dec 2020
- Primary completion30 Jan 2021
- Study completion20 Feb 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for End Stage Renal DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- Andrzej Frycz Modrzewski Krakow University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Paulina Kurleto, Andrzej Frycz Modrzewski Krakow University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04789122
- Sponsor's protocol ID
- WLNZ/NoZ/4/2020
- Status last verified
- Mar 2021
- First submitted
- 26 Feb 2021
- Last updated
- 9 Mar 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Kurleto P, Tomaszek L, Milaniak I, Bramstedt KA. Polish attitudes towards unspecified kidney donation: a cross-sectional study. BMC Nephrol. 2022 Apr 13;23(1):142. doi: 10.1186/s12882-022-02767-x.
PubMed 35418039Kurleto P, Tomaszek L, Milaniak I, Medrzycka-Dabrowska W. Factors Associated with the Willingness to Become a Living Kidney Donor: A National Cross-Sectional Study. Int J Environ Res Public Health. 2022 Jan 25;19(3):1313. doi: 10.3390/ijerph19031313.
PubMed 35162337
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Poles' Attitudes Towards Living Kidney Donation
- ClinicalTrials.gov ID
- NCT04789122
- Acronym / sponsor ID
- WLNZ/NoZ/4/2020
- Conditions
- End Stage Renal Disease
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,000 participants (actual)
- Lead sponsor
- Andrzej Frycz Modrzewski Krakow UniversityUniversity, hospital or other
- Study start
- 10 Dec 2020 (actual)
- Primary completion
- 30 Jan 2021 (actual)
- Study completion
- 20 Feb 2021 (actual)
- First posted
- 9 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main goal of the project is to examine the public opinion on living kidney donation and to assess the knowledge of Poles in this field.
Detailed description
Researchers also want to estimate how large percentage of the respondents will declare their willingness to donate a kidney to a stranger and what percentage of respondents would support a possible extension of the existing law on the collection, storage and transplantation of cells, tissues and organs of July 1, 2005 to include donation to a stranger.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Poles randomly chosen from all voivodships,
Key inclusion criteria (2 listed)
- 18 years or older
- Polish citizenship
Key exclusion criteria (2 listed)
- below 18 yers of age
- not Polish citizen
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Attitude assessmentThe study covered a representative group of 1000 people. Own questionnaire and standardized tools sent online via the Statistical Research and Analysis Office, in compliance with the privacy policy and personal data protection of the General Data Protection Regulation. | Other | – |
Primary outcome
Questionnaire answers under statistical processing
Time frame: 15.03.2021
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2021.
- Derived from this study: PubMed 35418039Kurleto P, Tomaszek L, Milaniak I, Bramstedt KA. Polish attitudes towards unspecified kidney donation: a cross-sectional study. BMC Nephrol. 2022 Apr 13;23(1):142. doi: 10.1186/s12882-022-02767-x.
- Derived from this study: PubMed 35162337Kurleto P, Tomaszek L, Milaniak I, Medrzycka-Dabrowska W. Factors Associated with the Willingness to Become a Living Kidney Donor: A National Cross-Sectional Study. Int J Environ Res Public Health. 2022 Jan 25;19(3):1313. doi: 10.3390/ijerph19031313.
- Individual participant dataSharing planned: Undecided
Related trials for End Stage Renal Disease
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingObservational study
Physical Impairments in Children With Chronic Renal Failure
Chronic Kidney Failure, Chronic Kidney Diseases
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End Stage Renal Disease, run by Andrzej Frycz Modrzewski Krakow University at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questionnaire answers under statistical processing (time frame: 15.03.2021). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04789122, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2021.